Real-time enrollment status for this solid tumors clinical trial
Current Status
Recruiting
Checked: October 2, 2026 at 1:03 AM UTC
| NCT Number | NCT07819136 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 90 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Recursion Pharmaceuticals Inc. |
| Last Updated on CT.gov | September 29, 2026 (3 days ago) |
As of October 2, 2026: Clinical trial NCT07819136 is currently recruiting participants. This phase1 study for solid tumors is actively seeking new participants at 3 locations across the United States. The study is sponsored by Recursion Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07819136 is actively recruiting participants as of October 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07819136 was last updated 3 days ago (September 29, 2026). HelloStudys verifies this status automatically.